# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-17-338771
Filing Date
2017-11-09
Accepted
2017-11-09 16:11:11
Documents
22
Period of Report
2017-11-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d490826d8k.htm | 8-K | 14622
2 | EX-99.1 | d490826dex991.htm | EX-99.1 | 29500
3 | EX-99.2 | d490826dex992.htm | EX-99.2 | 15044
4 | GRAPHIC | g490826ex99_2s10g1.jpg | GRAPHIC | 296223
5 | GRAPHIC | g490826ex99_2s11g1.jpg | GRAPHIC | 248888
6 | GRAPHIC | g490826ex99_2s12g1.jpg | GRAPHIC | 256140
7 | GRAPHIC | g490826ex99_2s13g1.jpg | GRAPHIC | 184112
8 | GRAPHIC | g490826ex99_2s14g1.jpg | GRAPHIC | 236693
9 | GRAPHIC | g490826ex99_2s15g1.jpg | GRAPHIC | 348404
10 | GRAPHIC | g490826ex99_2s16g1.jpg | GRAPHIC | 227431
11 | GRAPHIC | g490826ex99_2s17g1.jpg | GRAPHIC | 322758
12 | GRAPHIC | g490826ex99_2s18g1.jpg | GRAPHIC | 243203
13 | GRAPHIC | g490826ex99_2s1g1.jpg | GRAPHIC | 148683
14 | GRAPHIC | g490826ex99_2s2g1.jpg | GRAPHIC | 335755
15 | GRAPHIC | g490826ex99_2s3g1.jpg | GRAPHIC | 293053
16 | GRAPHIC | g490826ex99_2s4g1.jpg | GRAPHIC | 263873
17 | GRAPHIC | g490826ex99_2s5g1.jpg | GRAPHIC | 255706
18 | GRAPHIC | g490826ex99_2s6g1.jpg | GRAPHIC | 246160
19 | GRAPHIC | g490826ex99_2s7g1.jpg | GRAPHIC | 200100
20 | GRAPHIC | g490826ex99_2s8g1.jpg | GRAPHIC | 312882
21 | GRAPHIC | g490826ex99_2s9g1.jpg | GRAPHIC | 354191
22 | GRAPHIC | g490826g1108122728927.jpg | GRAPHIC | 3262
| Complete submission text file | 0001193125-17-338771.txt |  | 6642613

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 171190928
SIC: 2834 Pharmaceutical Preparations